P1–343: A phase II study of the gamma‐secretase inhibitor avagacestat (BMS‐708163) in predementia Alzheimer's disease. (1st July 2013) - Coric, Vlad; Salloway, Stephen; van Dyck, Christopher; Kerselaers, Wendy; Kaplita, Stephen; Curtis, Craig; Ross, Joel; Richter, Ralph W.; Andreasen, Niels; Brody, Mark; Sharma, Sanjiv K.; Cedarbaum, Jesse M.; et al.